Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients

Pentraxin 3 (PTX3), a multifunctional modulator of the innate immunoinflammatory response, is higher in patients undergoing hemodialysis than healthy control. Our study focused on annual change in PTX3 levels in patients with chronic hemodialysis, because regularly undergoing hemodialysis for many y...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Kei, Ueda, Atsushi, Saito, Chie, Zempo-Miyaki, Asako, Yamagata, Kunihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283416/
https://www.ncbi.nlm.nih.gov/pubmed/25587447
http://dx.doi.org/10.1155/2014/297954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283416/
https://www.ncbi.nlm.nih.gov/pubmed/25587447
http://dx.doi.org/10.1155/2014/297954

Ejemplares similares